Legend Biotech Corporation (NASDAQ ... It puts CARVYKTI in the enviable position of providing patients with longer lives, ...

M Therapeutics Inc. (4MTx), an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative diseases, today announced that the Company has been awarded a $120,000 ...

We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...

When it comes to pharma and biotech giants, Risinger and Leerink concluded ... Under Khan, the FTC opposed Illumina’s (NASDAQ ...

Grail Inc. (GRAL) Grail is a biotechnology leader that has a troubled history with parent firm Illumina Inc. (ILMN), a top genomic sequencing company. Namely, Illumina built Grail internally, spun it ...

As of November 08, 2024, GRAIL, Inc. had a $449.6 million market capitalization, putting it in the 39th percentile of companies in the Biotechnology industry. GRAIL, Inc. does not have a meaningful ...

Volunteers aged between 50 and 77 are being sought to trial the diagnostic developed by California biotech Grail, which spun out of Illumina in 2016 and agreed to be reacquired by the lab ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

Today, John Hancock, a unit of Toronto-based Manulife, announced it is providing free access to Galleri®, GRAIL's multi-cancer early detection (MCED) test, to special operations veterans receiving ...

They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...

Berlin-based Quantune is trying to shrink laser spectrometers so that you can wear one on your wrist, and it just raised $9M ...

But one of the most powerful aspiring entrants, Novo Nordisk, may not be as intimidating for the biotech as it once was. Novo's molecule semaglutide (commonly known by the trade names Ozempic and ...